Point-of-Care medical device development for high sensitivity multiplexed detection of blood biomarkers for health care management of cardiac patients
Published : 8 February 2020
Health systems must adapt to new societal and economic constraints that constitute an important challenge to address for the health of tomorrow. In this context, the development of Point-of-Care (POC) devices to carry out in vitro analyses provide valuable assistance to the decision-making of the practitioner for the diagnosis and/or prognosis of the disease. In this context, we propose a PhD subject to explore a new strategy to quantify blood biomarkers (proteins, peptides). This strategy is an alternative to the ELISA gold standard method, based on immuno-detection coupled to enzymatic amplification. We propose an innovative approach to develop a medical device for the high sensitivity detection of various significant blood biomarkers for cardiac diseases. The employed strategy is based on the use of original reagents (aptamers) allowing an isothermal multiplex biomolecular amplification, fast and highly sensitive, coupled with protocol integration and automation inside dedicated microfluidic cartridges. The developed biomedical device will be tested on clinical samples.